SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-17-195381
Filing Date
2017-06-06
Accepted
2017-06-06 09:09:14
Documents
9
Effectiveness Date
2017-06-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d314135ddefm14a.htm DEFM14A 1511737
2 GRAPHIC g314135g02s74.jpg GRAPHIC 9832
3 GRAPHIC g314135g07a35.jpg GRAPHIC 26550
4 GRAPHIC g314135g11k49.jpg GRAPHIC 25218
5 GRAPHIC g314135g33p82.jpg GRAPHIC 28992
6 GRAPHIC g314135g53n91.jpg GRAPHIC 22770
7 GRAPHIC g314135g78k28.jpg GRAPHIC 3599
8 GRAPHIC g314135pc1.jpg GRAPHIC 127284
9 GRAPHIC g314135pc2.jpg GRAPHIC 123134
  Complete submission text file 0001193125-17-195381.txt   2019521
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
ALERE INC. (Filer) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-16789 | Film No.: 17893158
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1